Karyn Goodman MD, MS, Associate Director for clinical research at the University of Colorado Cancer Center, has been awarded the David and Margaret Turley Grohne Chair in Clinical Cancer.
Goodman is a board-certified radiation oncologist specializing in cancers of the gastrointestinal tract, including malignancies of the esophagus, stomach, pancreas, and liver as well as colorectal cancer. Goodman’s interests include developing more sophisticated techniques to deliver radiotherapy to improve outcomes for patients with gastrointestinal cancers.
“Radiation therapy is a vital, effective tool in treating cancer,” says Goodman, who also is a Professor in the University of Colorado School of Medicine’s Department of Radiation Oncology. “The Grohne’s generosity will allow me to continue my work in finding novel ways to deliver radiotherapy more effectively and to evaluate combinations of radiotherapy and new therapies such as immunotherapy. It also will allow me to continue looking for ways of improving quality of life for people with cancer.”
Goodman’s work helps to define treatment protocols for combination therapies including radiation, chemotherapy, and novel agents for gastrointestinal cancers. Her research also explores quality of life and late onset side effects that some patients experience long after radiotherapy. She received an American Society of Clinical Oncology Young Investigator Award to study late effects of therapy for patients with relapsed and refractory Hodgkin’s Lymphoma, including the incidence of second cancers such as breast cancer. She also is particularly interested in women’s health after radiation therapy including preserving fertility and sexual health.
“Dr. Goodman has been at the CU Cancer Center for just 18 months,” said Dan Theodorescu, MD, PhD, director of the CU Cancer Center and professor of surgery and pharmacology at CU School of Medicine. ”She already has had a tremendous impact on clinical trial operations, improving communication and efficiency. Dr. Goodman is also at the forefront of our efforts to bring clinical trials to more patients across the state of Colorado.”
Margaret and David Grohne, among the CU Cancer Center’s most generous donors, have donated more than $10 million to support cancer research. Their most recent gifts are in support of breast cancer, cancer stem cell and cancer vaccine research.
Mrs. Grohne is a breast cancer survivor.
The Grohnes also fund the David F. and Margaret Turley Grohne Chair in Basic/Translational Cancer Research and the David and Margaret Turley Grohne Chair in Cancer Prevention and Control Research.